Monday 28th August 2017 |
Text too small? |
Abano Healthcare said it successfully completed the shortfall bookbuild component of the $35 million capital raise announced on July 26, with strong investor support.
Last week the Australasian radiology and dental centre operator said 3,878,946 new shares, at a price of $8.15 per share, were taken up by shareholders under its fully underwritten 1 for 5 pro rata renounceable rights offer, representing approximately 92 percent of the new shares available to eligible shareholders under the rights offer.
As a result, it opened a shortfall bookbuild for the remaining 413,563 shares, conducted by Forsyth Barr.
At the time, it said shareholders who did not take up their full entitlements in the rights offer would receive a share of any premium achieved for the rights which they did not take up.
The clearing price under the shortfall bookbuild was $9.25 per share, a premium of $1.10 per share over the application price of $8.15 under the offer. Therefore, eligible shareholders who did not take up their full entitlements will receive $1.10 for each new share not taken up by them. Payment is expected to be made on Sept 1.
The shares taken up under the offer are expected to be allotted and commence trading Aug 30, it said.
The stock was unchanged at $9.28 and is up 22 percent over the past 12 months.
(BusinessDesk)
No comments yet
GTK - Half-Year Results Announcement Date
Government ends war on farming
Sky and BBC Studios renew expanded, multi-year agreement
AOF - Q1 Improved Trading Performance & FY24 Guidance Maintained
Devon Funds Morning Note - 23 April 2024
April 23rd Morning Report
RYM - Group CEO Update
BGI - Director Michael Chai
RAD - Final Dividend and Strong FY24 Operating Performance
RYM - Group CEO Update